InsidersTradesSigma
엘앤케이바이오: directors' dealings · South Korea · DART (FSS)
DART:company-e52017KR·DART (FSS)Mcap 269.0Bn€
Explore the full directors' dealings record of 엘앤케이바이오, a listed issuer based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Market capitalisation: €269bn. The latest transaction was reported on 17 April 2026 — Purchase. Among the most active insiders: 강국진. The full history is free.
2
Insider Decl.
0
Thresholds
·
2 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
5960.00 €
Income statement
Revenue38.92 Bn€
Gross profit32.16 Bn€83% margin
Net income−16.30 Bn€-41.9% margin
Balance sheet & cash
Market cap268.99 Bn€
Total debt19.15 Bn€
Free Cash Flow−17.01 Bn€
Last declaration on 17 April 2026